Elevance Reports Q3 2024 Earnings with Lower-Than-Expected EPS and Revenue Growth
Elevance (ELV) reported Q3 2024 earnings with adjusted diluted EPS of $8.37, below internal expectations due to higher Medicaid medical costs. Total operating revenue rose 5% year-over-year to $44.7 billion, but the company revised its 2024 adjusted EPS outlook downward to approximately $33.
Tickers: $ELV
Topics: Earnings EPS Medicaid Costs Operating Expenses Revenue